CN103079574B - 用于控制口唇疱疹、生殖器疱疹及带状疱疹复发的聚乙二醇组合物 - Google Patents

用于控制口唇疱疹、生殖器疱疹及带状疱疹复发的聚乙二醇组合物 Download PDF

Info

Publication number
CN103079574B
CN103079574B CN201180033948.1A CN201180033948A CN103079574B CN 103079574 B CN103079574 B CN 103079574B CN 201180033948 A CN201180033948 A CN 201180033948A CN 103079574 B CN103079574 B CN 103079574B
Authority
CN
China
Prior art keywords
peg
polyethylene glycol
herpes
weight
topical administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180033948.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN103079574A (zh
Inventor
彼得·维廷斯
马塞尔·朗根奥尔
保罗·马丁·舍雷尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devirex AG
Original Assignee
Devirex AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex AG filed Critical Devirex AG
Publication of CN103079574A publication Critical patent/CN103079574A/zh
Application granted granted Critical
Publication of CN103079574B publication Critical patent/CN103079574B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201180033948.1A 2010-07-08 2011-07-08 用于控制口唇疱疹、生殖器疱疹及带状疱疹复发的聚乙二醇组合物 Active CN103079574B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
US61/362,329 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (2)

Publication Number Publication Date
CN103079574A CN103079574A (zh) 2013-05-01
CN103079574B true CN103079574B (zh) 2017-04-12

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180033948.1A Active CN103079574B (zh) 2010-07-08 2011-07-08 用于控制口唇疱疹、生殖器疱疹及带状疱疹复发的聚乙二醇组合物

Country Status (20)

Country Link
US (2) US9814743B2 (enExample)
EP (1) EP2563374B1 (enExample)
JP (1) JP5858994B2 (enExample)
KR (1) KR101881175B1 (enExample)
CN (1) CN103079574B (enExample)
AU (1) AU2011275458B2 (enExample)
CA (1) CA2803228C (enExample)
DK (1) DK2563374T3 (enExample)
ES (1) ES2442928T3 (enExample)
HR (1) HRP20140135T1 (enExample)
IL (1) IL223582A (enExample)
MX (1) MX2012014783A (enExample)
PL (1) PL2563374T3 (enExample)
PT (1) PT2563374E (enExample)
RS (1) RS53162B (enExample)
RU (1) RU2643763C2 (enExample)
SG (1) SG186937A1 (enExample)
SI (1) SI2563374T1 (enExample)
WO (1) WO2012004669A1 (enExample)
ZA (1) ZA201300177B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2563374T1 (sl) 2010-07-08 2014-01-31 Devirex Ag Polietilenglikolni sestavki za nadzorovanje relapsa herpesa labialisa, herpesa genitalisa in herpesa zostra
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
BR112015019598B1 (pt) 2013-02-19 2020-06-23 Johnson & Johnson Consumer Inc. Métodos para aprimorar a aparência de e/ou reduzir substancialmente a formação de cicatrizes e outros efeitos visíveis de feridas curadas, quelóides e cicatrizes hipertróficas
ES2538335T3 (es) * 2013-05-14 2015-06-19 Najöpharm Gmbh I.G. Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
TW201825095A (zh) * 2016-11-28 2018-07-16 德商艾庫里斯抗感染治療有限公司 包含n-[5-(胺基磺醯基)-4-甲基-1,3-噻唑-2-基]-n-甲基-2-[4-(2-吡啶基)-苯基]-乙醯胺之局部醫藥調配物
EP3962924A1 (en) 2019-05-03 2022-03-09 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
WO2021233571A1 (de) * 2020-04-30 2021-11-25 Ninoderm Ug (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387398B1 (en) * 1998-07-22 2002-05-14 Dragoco Gerberding & Co. Ag Process for producing cosmetic and pharmaceutical formulations, and products comprising same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
CA2675190A1 (en) 2007-01-17 2008-07-24 Devirex Ag Cyclodextrin formulations
SI2563374T1 (sl) 2010-07-08 2014-01-31 Devirex Ag Polietilenglikolni sestavki za nadzorovanje relapsa herpesa labialisa, herpesa genitalisa in herpesa zostra
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387398B1 (en) * 1998-07-22 2002-05-14 Dragoco Gerberding & Co. Ag Process for producing cosmetic and pharmaceutical formulations, and products comprising same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《ADDITION OF ANTIOXIDANTS AND POLYETHYLENE GLYCOL 4000 ENHANCES THE HEALING PROPERTY OF HONEY IN BURNS》;Subrahmanyam N.;《annals of burns and fire disasters》;19960630;第ix卷(第2期);1-4页 *

Also Published As

Publication number Publication date
ZA201300177B (en) 2014-03-26
JP5858994B2 (ja) 2016-02-10
AU2011275458B2 (en) 2014-11-27
US20180055875A1 (en) 2018-03-01
AU2011275458A1 (en) 2013-02-28
EP2563374B1 (en) 2013-11-13
KR101881175B1 (ko) 2018-07-23
HRP20140135T1 (hr) 2014-03-28
SI2563374T1 (sl) 2014-01-31
SG186937A1 (en) 2013-02-28
RU2643763C2 (ru) 2018-02-05
US9814743B2 (en) 2017-11-14
RU2013100383A (ru) 2014-08-20
KR20130142992A (ko) 2013-12-30
JP2013530208A (ja) 2013-07-25
PT2563374E (pt) 2014-01-23
EP2563374A1 (en) 2013-03-06
WO2012004669A1 (en) 2012-01-12
PL2563374T3 (pl) 2014-04-30
RS53162B (sr) 2014-06-30
US20130090389A1 (en) 2013-04-11
CA2803228A1 (en) 2012-01-12
ES2442928T3 (es) 2014-02-14
MX2012014783A (es) 2013-04-03
HK1180969A1 (en) 2013-11-01
DK2563374T3 (da) 2014-01-20
IL223582A (en) 2017-12-31
CN103079574A (zh) 2013-05-01
CA2803228C (en) 2019-03-12

Similar Documents

Publication Publication Date Title
CN103079574B (zh) 用于控制口唇疱疹、生殖器疱疹及带状疱疹复发的聚乙二醇组合物
US20100111883A1 (en) Cyclodextrin formulations
KR20220044558A (ko) 칸나비디올을 포함하는 외용 제제, 조성물의 제조 방법 및 이의 용도
WO2017011785A1 (en) Topical antiviral formulations and methods of using the same
KR20190026962A (ko) 세균질증 치료에 사용하기 위한 세크니다졸
Spector Management of asthma with zafirlukast: clinical experience and tolerability profile
DK2343038T3 (en) Dermatological compositions containing a combination of peroxidized lipids and zinc and their use, especially for the treatment of herpes
WO2013102885A1 (en) Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
BR112020004337A2 (pt) composição, composição farmacêutica, dispositivo e processo de fabricação da composição
US20060154983A1 (en) Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
HK1180969B (en) Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
JP2005519868A (ja) ｎ−ドコサノールによるウイルス阻害
EP0078533B1 (en) Medicinal composition for treating skin disorders
JP2006327966A (ja) 皮膚外用剤とその適用
Agent Docosanol Cream, 10%
Altaei et al. The efficacy of topically applied silymarin in the treatment of herpes labialis ulcers
Kroon Herpes simplex virus infection (orofacial)
ITUB20159325A1 (it) Uso di un estratto o concentrato di gelso nero per la preparazione di prodotti cosmetici o integratori alimentari, e prodotti cosmetici o integratori alimentari cosi preparati

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant